Patents
US 11690825 B2: 20-HETE receptor (GPR75) antagonists and methods of use
- Granted
- 2023-07-04
- Filed
- 2017-03-08 application 16083404
- Type
- Utility · 28 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention concerns compounds and their use to treat cardiovascular disease, renal disease, thrombic disease, stroke, metabolic syndrome, cell proliferation, and ischemic cardiovascular disorders. Compounds of the present invention display significant potency as antagonists of 20-hydroxyeicosatetraenoic acid (20-HETE), and function as anti-hypertensive, anti-inflammatory, or anti-growth agents.
Source: PVGPATDIS, file of 2026-04-10 (ipg230704.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 3,356 patents | US company or organization | Austin, TX | PVGPATDIS, file of 2026-04-10 | |
| NEW YORK MEDICAL COLLEGE 19 patents | US company or organization | Valhalla, NY | New York Medical College College or university EXACT high confidence: identical full name and state NEW YORK MEDICAL COLLEGE Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| John R. Falck | Austin, TX | 20 | PVGPATDIS, file of 2026-04-10 | |
| Michal L. Schwartzman | Valhalla, NY | 1 | Person page FUZZY medium confidence | PVGPATDIS, file of 2026-04-10 |
| Victor Garcia | Valhalla, NY | 5 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| G01N | Investigating or analysing materials by determining their chemical or physical properties | G01N33/92 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/231 | PVGPATDIS, file of 2026-04-10 |
| C07C | Acyclic or carbocyclic compounds | C07C57/52 | PVGPATDIS, file of 2026-04-10 |
| C40B | Combinatorial chemistry; libraries, e.g. chemical libraries | C40B30/04 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P13/12 | PVGPATDIS, file of 2026-04-10 |
| C07B | General methods of organic chemistry; apparatus therefor | C07B2200/07 | PVGPATDIS, file of 2026-04-10 |
| C07D | Heterocyclic compounds | C07D257/04 | PVGPATDIS, file of 2026-04-10 |
| C07K | Peptides | C07K14/723 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2025-02-24 | Assignment Assignment of assignor's interest | GARCIA, VICTOR signed 2016-05-05 SCHWARTZMAN, MICHAL L. signed 2017-01-04 | NEW YORK MEDICAL COLLEGE VALHALLA, NY | 70305/367 | ECORSEXC, file of 2026-09-25 |
| 2025-02-24 | Assignment Assignment of assignor's interest | FALCK, JOHN R. signed 2016-03-23 | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM AUSTIN, TX | 70305/20 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.